PROTHENA CORPORATION PUBLIC LIMITED COMPANY Other Current Assets
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Other Current Assets of $2.58 million as of 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2020-03-03
- 2019-12-31: Other Assets, Current $2.58M.
- 2019-09-30: Other Assets, Current $3.15M.
- 2019-06-30: Other Assets, Current $3.46M.
- 2018-12-31: Other Assets, Current $3.73M; Other Assets, Current as first filed $3.73M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2019-12-31 | $2.58M 10-K · filed 2020-03-03 | |
| 2019-09-30 | $3.15M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.46M 10-Q · filed 2019-08-06 | |
| 2018-12-31 | $3.73M 10-K · filed 2020-03-03 | $3.73M 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |